Navigation Links
arGEN-X Presents Significant Progress at BioPharm America 2011
Date:9/7/2011

ROTTERDAM, The Netherlands, September 7, 2011 /PRNewswire/ --

SIMPLE Antibody™ platform continues to demonstrate clear advantages in therapeutic antibody discovery


arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies using its proprietary SIMPLE Antibody™ platform, will provide an update on this year's significant corporate progress  during a presentation by its CEO Tim Van Hauwermeiren at the BioPharm America conference in Boston, MA, USA (http://www.ebdgroup.com/bpa/).

In his presentation on Friday, September 9, Mr. Van Hauwermeiren will showcase the speed with which arGEN-X has developed its pipeline of novel therapeutic antibody candidates in cancer and inflammatory disease. In less than two years of operations, the Company has identified three completely novel lead antibodies of unprecedented specificity and potency and progressed them into preclinical studies. arGEN-X is also combining the power of its SIMPLE Antibody™ platform with POTELLIGENT® Technology licensed from BioWa, Inc., to increase the cytotoxic potency of its therapeutic leads even further.

The arGEN-X presentation will also announce the successful fulfilment of all milestones in its first biopharma collaboration, only five months from its initiation in January 2011. Upon completion of this program, arGEN-X delivered a panel of unique, diverse antibodies against a technically complex target provided by the partner. This success demonstrated how the SIMPLE Antibody™ platform could generate antibodies with outstanding qualities, even against targets beyond the reach of other antibody platforms.

Speaking further about the exciting developments at arGEN-X, Mr. Van Hauwermeiren said:

"The signficant progress we have made in 2011 is proof that our unique SIMPLE Antibody™ Platform is tra
'/>"/>

SOURCE arGEN-X
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
2. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
3. arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development
4. arGEN-X Concludes EUR 12.5 Million Series A Financing Round
5. Elan Pharmaceuticals Presents 7th Annual Danville Concours dElegance Weekend
6. Codexis Presents Carbon Capture Update at DoE/NETL Conference
7. Cardium Presents Second Quarter 2011 Financial Results and Reports on Near-Term Milestones
8. Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimers Disease Research
9. Amerigroup Foundation Presents Grant to Rx Partnership
10. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
11. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Grammy Award-winner Bruce Hornsby will ... philanthropists, athletes, actors, and musicians during the 10 th ... at the Mandarin Oriental Hotel in New ... honor six individuals who embody the values of the ... its highest honor, the Spirit of an Active Lifestyle ...
(Date:10/31/2014)... Imago BioSciences, Inc., a biotech company ... Series A financing led by Clarus Ventures LLC, ... of accomplished investment and operating professionals dedicated to ... include Frazier Healthcare, Amgen Ventures, and Merck Research ... Frazier Healthcare will join the company,s board of ...
(Date:10/31/2014)... Investor-Edge has initiated coverage on ... ), Isis Pharmaceuticals Inc. (NASDAQ: ISIS ), ... Pharmaceuticals Inc. (NASDAQ: ACAD ), and Synta ... companies can be accessed at: http://investor-edge.com/register . ... ended at 4,566.14, up 0.37%, the Dow Jones Industrial ...
Breaking Medicine Technology:10th Anniversary Orthopaedic Foundation Gala Set For Success 2Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5
... WORTH, Texas, March 3, 2011 A new report ... residents of 12 counties in East Texas are breathing a ... conducted by the health science center,s Center for Professional ... chronic obstructive pulmonary disease (COPD).  The report shows ...
... March 3, 2011 AORN Works , a ... announced that its market research and surgical insights division ... (Logo: http://photos.prnewswire.com/prnh/20101001/DC75398LOGO ) ... attitudes of perioperative professionals who are the end users ...
Cached Medicine Technology:Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 2Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 3Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 4Advanced Market Research for Medical Device Manufacturers 2
(Date:10/31/2014)... Chico, CA. (PRWEB) October 31, 2014 ... best known for its small scale BioPro™ biodiesel ... equipment that will further improve the performance and ... , The GL95/MC12/BD380 trio will recover ... is mixed in with the glycerin by-product produced ...
(Date:10/31/2014)... Research Center for Healthy Neighborhoods (PRCHN) at Case ... key player in nearly $13.32 million in federal ... Ohio. , The Centers for Disease Control and ... million over five years. The funds will support ... disseminating individual, environmental, and policy interventions that prevent ...
(Date:10/31/2014)... Colorado (PRWEB) October 31, 2014 The Memory ... was created by Alexander Lynch, whose father suffered from Alzheimer's ... a dramatic moment, caused by his father's disease. His father ... That was the crucial moment when the author of this ... his dad. , The Memory Healer program is based ...
(Date:10/31/2014)... 2014 Monica Williams-Murphy MD , ... too well the chaos that can occur for people ... vast majority of Americans who come into the emergency ... completely unprepared for the moment and so are their ... serve as a catalyst for a family to get ...
(Date:10/31/2014)... Summit, Missouri (PRWEB) October 31, 2014 ... the country about families narrowly escaping carbon monoxide poisoning ... season) looms just weeks away, one family-owned, Missouri-based heating ... straightforward approach to making sure families start the home ... are safe and secure. , Beginning Nov. 1, ...
Breaking Medicine News(10 mins):Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 2Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 3Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3
... at the Imperial College London it was found that lab ... , It was believed that early exposure to ... lab workers who frequently handled research rodents had fewer allergic ... to be protective against eczema allergy. The study results are ...
... a stroke, caused either by a blocked or burst blood vessel ... die. ,That's the bad news. ,And the good news! ... problems that cause many strokes — before a stroke ever happens. ... the skull. ,New technologies, delivered to the brain via ...
... who is now 42 years old has been slightly unconscious and ... His nerves were completely sheared in a car crash and he ... others by means of grunts and nods. But now his speech ... the tiny nerve connections in his brain slowly started to rewire. ...
... conducted by the Korean scientists from the Korea Research Institute of ... that the research team has found a human gene that aids ... The researchers were very happy about the discovery and said that ... cancers. ,The study was mainly conducted on mice and ...
... Haryana Government has decided to start a two year ... in Panchakarma at Shri Krishna Government// Ayurvedic College at ... diploma courses has already been formulated and these courses ... state Health Minister Kartar Devi told reporters here., ...
... to be far from the goal of any reversal of the ... in cases of drug abuse in all of Europe//. The statistics ... abuse category and a rank 3 in cocaine and ecstasy abuse. ... abuse. ,As per the drug policy of the government, ...
Cached Medicine News:Health News:Brain Surgery Without the Surgery? 2Health News:Brain Surgery Without the Surgery? 3Health News:Brain Surgery Without the Surgery? 4Health News:Brain Surgery Without the Surgery? 5Health News:Brain Surgery Without the Surgery? 6
... SAFE-T-FILL Capillary Blood Collection Tubes are 100% ... a wide range of applications, the Capillary ... tube, attached cap and a micro tube.,The ... the blood into the micro tube thereby ...
... Scientifics SAFE-T-FILL Capillary Blood Collection Tubes are ... for a wide range of applications, the ... capillary tube, attached cap and a micro ... draw the blood into the micro tube ...
... The Bio-Rad Mumps IgG test is an ... Test results are obtained after a 90-minute incubation. ... index values, permitting uniformity of reporting. The ... qualitative and semi-quantitative detection of human IgG antibodies ...
... Bio-Rad Measles IgG test is an enzyme immunoassay ... are obtained after a 90-minute incubation. The ... permitting uniformity of results. The Bio-Rad Measles ... semi-quantitative detection of human IgG antibodies to measles ...
Medicine Products: